{"id":935059,"date":"2026-02-08T16:21:02","date_gmt":"2026-02-08T21:21:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/"},"modified":"2026-02-08T16:21:02","modified_gmt":"2026-02-08T21:21:02","slug":"tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/","title":{"rendered":"TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis"},"content":{"rendered":"

\nCampaign debuted during Super Bowl LX and introduced www.NextInMS.com, a new platform designed to create space for honest conversation among people living with MS
\n<\/h2>\n
\n

\n Final Live Snippet<\/a>\n <\/p>\n

\n A Media Snippet accompanying this announcement is available by clicking on this link.<\/a>\n <\/p>\n

NEW YORK, Feb. 08, 2026 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced a collaboration with actress Christina Applegate to help raise awareness of multiple sclerosis (MS) and support meaningful conversations for those living with the disease.<\/p>\n

Christina Applegate, who has been living with MS for 5 years, will lead the new national disease-awareness initiative designed to elevate the voices of people living with MS, highlight the realities, and explore what comes next, on their own terms.<\/p>\n

The cornerstone of the campaign is www.NextInMS.com<\/a>, a new platform developed to support people living with MS. Through Next In MSTM<\/sup><\/a>, Christina extends the same unfiltered honesty she has brought to her own experience into shared conversations with others living with MS. The platform will feature exclusive content including Christina\u2019s personal perspectives on navigating life with MS, long-term decision-making, engaging with the healthcare system, and prioritizing quality of life while living with a chronic condition. It is expected to also include educational content from leading MS experts offering current insights on topics of interest to the MS community. Together, these efforts are intended to foster open, informed dialogue among people living with MS, caregivers, and healthcare professionals.<\/p>\n

\u201cMS isn\u2019t something you neatly figure out and move on from \u2014 it\u2019s messy, it\u2019s unpredictable and some days it frankly just sucks,\u201d said Christina Applegate. \u201cI\u2019ve always tried to be honest about that. Next In MS is about opening up those conversations, expanding our understanding and always being prepared for what\u2019s next. I\u2019m excited to be partnering with TG Therapeutics, and together hopefully we can reach more members of the MS community, cut through the noise and talk openly about the truths of living with MS \u2014 the challenging ones and the hopeful ones too.\u201d<\/p>\n

Michael S. Weiss, Chairman and Chief Executive Officer of TG Therapeutics, added, \u201cChristina brings a level of openness and authenticity that resonates deeply with us at TG. We\u2019re honored to collaborate with her as she shares her perspective and as we collectively look toward what\u2019s next in MS. At TG Therapeutics, we remain committed to advancing innovation and supporting efforts that keep those living with MS at the center of everything we do.\u201d<\/p>\n

TG\u2019s focus on advancing innovation in multiple sclerosis includes not only the development of novel therapies, but also a commitment to supporting resources that help people living with MS feel informed and empowered throughout their care journey.<\/p>\n

\n ABOUT <\/strong>
\n
\n WWW.NEXTINMS.COM<\/strong>
\n <\/a>
\n
\n Next In MSTM<\/sup><\/a> is a platform designed to create space for people living with MS to have honest conversations about their experience and explore together what comes next, on their own terms. The platform centers on real, unfiltered dialogue, including conversations between Christina Applegate and others living with MS, and reflects the everyday realities, questions, and decisions that shape life with the disease. Next In MS is intended to support people living with MS in carrying that openness beyond the platform, into conversations with family members, friends, and healthcare professionals, when and how they choose. The platform is designed to evolve over time as those conversations continue.<\/p>\n

\n ABOUT TG THERAPEUTICS<\/strong>\u00a0
TG Therapeutics is a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition,\u00a0development\u00a0and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline,\u00a0TG Therapeutics has\u00a0a product approved by\u00a0the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsing forms of multiple sclerosis,\u00a0including clinically\u00a0isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, and by\u00a0several regulatory agencies outside of the U.S\u00a0to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit\u00a0www.tgtherapeutics.com,<\/u><\/a>\u00a0and follow us on X @TGTherapeutics<\/u><\/a>\u00a0and on\u00a0LinkedIn<\/u><\/a>.<\/p>\n

Cautionary Statement<\/strong>
This press release contains forward-looking statements that involve a number of risks and uncertainties. All statements contained in this press release other than statements of historical facts, including statements regarding our collaboration with Christina Applegate, and the www.nextinms.com<\/a> platform may constitute forward-looking statements. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.<\/p>\n

Any forward-looking statements in this press release are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release.<\/p>\n

Additional factors that could cause our actual results to differ materially include the following: the Company\u2019s ability to continue to commercialize their marketed product; the risk that the collaboration with Christina Applegate, does not go as planned; the risk that the www.nextinms.com platform does not gain traction or ceases to exist; the risk that due to regulatory enforcement or other reasons any portion of the collaboration described today is not able to be implemented; the risk that the Company does not achieve its 2026 development pipeline anticipated milestones or goals in the timeframe projected or at all; the uncertainties generally inherent in research and development; regulatory developments, legislative actions, executive orders, including the imposition of tariffs and policy changes in the U.S. and other jurisdictions; and general political, economic and business conditions. Further discussion about these and other risks and uncertainties can be found in our Annual Report on Form 10-K for the fiscal year ended\u00a0December 31, 2024 and in our other filings with the\u00a0Securities and Exchange Commission.<\/p>\n

Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at\u00a0www.tgtherapeutics.com<\/a>. The information found on our website is not incorporated by reference into this press release and is included for reference purposes only.<\/p>\n

CONTACT:<\/p>\n

\n Investor Relations<\/strong>
\n
Email:ir@tgtxinc.com<\/a>
Telephone: 1.877.575.TGTX (8489), Option 4<\/p>\n

\n Media Relations<\/strong>
\n
Email:media@tgtxinc.com<\/a>
Telephone: 1.877.575.TGTX (8489), Option 6<\/p>\n

\n
\n 1.<\/strong>
\n <\/sup>
\n \u00a0MS Prevalence. National Multiple Sclerosis Society website.\u00a0<\/sup>
\n
\n https:\/\/www.nationalmssociety.org\/About-the-Society\/MS-Prevalence<\/sup>
\n <\/a>
\n . Accessed October 26, 2020.<\/sup>
\n
\n \u00a02.<\/strong>
\n <\/sup>
\n \u00a0Multiple Sclerosis International Federation, 2013 via\u00a0Data monitor\u00a0p. 236.<\/sup>\n <\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Campaign debuted during Super Bowl LX and introduced www.NextInMS.com, a new platform designed to create space for honest conversation among people living with MS Final Live Snippet A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Feb. 08, 2026 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced a collaboration with actress Christina Applegate to help raise awareness of multiple sclerosis (MS) and support meaningful conversations for those living with the disease. Christina Applegate, who has been living with MS for 5 years, will lead the new national disease-awareness initiative designed to elevate the voices of people living with MS, highlight the realities, and explore what comes next, on their own terms. The … <\/p>\n

Continue reading “TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-935059","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Campaign debuted during Super Bowl LX and introduced www.NextInMS.com, a new platform designed to create space for honest conversation among people living with MS Final Live Snippet A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Feb. 08, 2026 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced a collaboration with actress Christina Applegate to help raise awareness of multiple sclerosis (MS) and support meaningful conversations for those living with the disease. Christina Applegate, who has been living with MS for 5 years, will lead the new national disease-awareness initiative designed to elevate the voices of people living with MS, highlight the realities, and explore what comes next, on their own terms. The … Continue reading "TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-08T21:21:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDkwNCM3NDE0NTg1IzIwMjA3OTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis\",\"datePublished\":\"2026-02-08T21:21:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\\\/\"},\"wordCount\":1096,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MDkwNCM3NDE0NTg1IzIwMjA3OTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\\\/\",\"name\":\"TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MDkwNCM3NDE0NTg1IzIwMjA3OTY=\",\"datePublished\":\"2026-02-08T21:21:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MDkwNCM3NDE0NTg1IzIwMjA3OTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MDkwNCM3NDE0NTg1IzIwMjA3OTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/","og_locale":"en_US","og_type":"article","og_title":"TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis - Market Newsdesk","og_description":"Campaign debuted during Super Bowl LX and introduced www.NextInMS.com, a new platform designed to create space for honest conversation among people living with MS Final Live Snippet A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Feb. 08, 2026 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced a collaboration with actress Christina Applegate to help raise awareness of multiple sclerosis (MS) and support meaningful conversations for those living with the disease. Christina Applegate, who has been living with MS for 5 years, will lead the new national disease-awareness initiative designed to elevate the voices of people living with MS, highlight the realities, and explore what comes next, on their own terms. The … Continue reading \"TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-08T21:21:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDkwNCM3NDE0NTg1IzIwMjA3OTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis","datePublished":"2026-02-08T21:21:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/"},"wordCount":1096,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDkwNCM3NDE0NTg1IzIwMjA3OTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/","name":"TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDkwNCM3NDE0NTg1IzIwMjA3OTY=","datePublished":"2026-02-08T21:21:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDkwNCM3NDE0NTg1IzIwMjA3OTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDkwNCM3NDE0NTg1IzIwMjA3OTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-announces-collaboration-with-christina-applegate-to-raise-awareness-of-multiple-sclerosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/935059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=935059"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/935059\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=935059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=935059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=935059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}